INFECTIONS ON DIFFERENT CHEMOTHERAPY CYCLES IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ALL-2009 PROTOCOL

INFECTIONS ON DIFFERENT CHEMOTHERAPY CYCLES IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ALL-2009 PROTOCOL

The aim of this study was to evaluate incidence and type of infections in patients with acute lymphoblastic leukemia (ALL) treated with ALL-2009 protocol during different chemotherapy cycles.Materials and methods. Prospective study (2013–2015) included patients with de novo ALL, receiving chemothera...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Okhmat, G. A. Klyasova, E. N. Parovichnikova, V. V. Troitskaya, E. O. Gribanova, A. O. Malchikova, A. G. Korobova, I. N. Frolova, V. G. Savchenko
Format:	Article
Language:	Russian
Published:	ABV-press 2017-10-01
Series:	Онкогематология
Subjects:	hematological malignancies acute leukemia febrile neutropenia infectious complications invasive mycosis
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/256
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Infectious complications in patients with acute leukemia according to the duration of neutropenia
by: V. A. Okhmat, et al.
Published: (2018-10-01)

Antibiotic Treatment of Febrile Neutropenia in Patients with Acute Leukemia
by: VA Okhmat, et al.
Published: (2018-01-01)

Infections in patients with acute luekemia treated with different regimens
by: T. N. Aleksandrova, et al.
Published: (2025-05-01)

Immunocorrective treatment use in the prevention of hematological and infectious complications of chemotherapy in cancer patients
by: L. Yu. Grivtsova, et al.
Published: (2021-11-01)

Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center
by: Arun B Karanwal, et al.
Published: (2013-01-01)

<i>In vitro</i> activity of cefepime / sulbactam and biapenem against Enterobacterales and <i>Pseudomonas aeruginosa</i> isolated from blood culture from patients with hematological diseases: results of a multicenter study
by: G. A. Klyasova, et al.
Published: (2023-05-01)

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01)

Level of Knowledge and Incidence of Emergency Oncology: Febrile Neutropenia in Hematologic Cancer Patients Post Chemotherapy: A Descriptive Study
by: Agus Suryaman
Published: (2024-12-01)

Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis
by: Leyla Yumrukaya, et al.
Published: (2025-06-01)

Secondary infections after cytotoxic chemotherapy in patient with hematological malignancies
by: Seyit Ali Büyüktuna, et al.
Published: (2017-07-01)

Thrombin generation in children with febrile neutropenia
by: Ayça Koca Yozgat, et al.
Published: (2021-04-01)

Current treatment options for infections caused by carbapenem-resistant Enterobacteriaceae in patients with hematological malignancies
by: G. A. Klyasova
Published: (2020-07-01)

A clinical case of pulmonary form of mucormycosis in a child with acute lymphoblastic leukemia
by: Yu. Yu. Kozel, et al.
Published: (2021-12-01)

The Pattern of Microorganism on Adult Acute Leukemia Patients During Bacterial Surveillance and Febrile Neutropenia at Cipto Mangunkusumo Hospital
by: Lugyanti Sukrisman
Published: (2021-03-01)

Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years
by: K Govind Babu, et al.
Published: (2016-01-01)

Evaluation of Risk Factors for Mortality in Febrile Neutropenia
by: Sabahat Ceken, et al.
Published: (2020-08-01)

COMPARISON OF ANTIMICROBIAL SENSITIVITY TO OLDER AND NEWER QUINOLONES VERSUS PIPERACILLIN-TAZOBACTAM, CEFEPIME AND MEROPENEM IN FEBRILE PATIENTS WITH CANCER IN TWO REFERRAL PEDIATRIC CENTERS IN TEHRAN, IRAN
by: Ali Nateghian, et al.
Published: (2014-06-01)

Clinical and microbiological characteristics of bacteremia caused by Streptococcus viridans in children with hematologic malignancies
by: M. V. Panina, et al.
Published: (2015-01-01)

Chemotherapy limiting neutropenia. Is prevention required?
by: I. B. Kononenko, et al.
Published: (2022-01-01)

Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer
by: L. G. Babicheva, et al.
Published: (2021-11-01)

Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia
by: Tyler Luu, et al.
Published: (2024-12-01)

2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
by: Michael Sandherr, et al.
Published: (2025-04-01)

Biomaterial-based drug delivery: evaluating the safety profiles of liposomal Vyxeos
by: Zhicheng Liu, et al.
Published: (2025-12-01)

Lipegfilgrastim in patients with chemotherapy-induced neutropenia
by: G. D. Petrova, et al.
Published: (2015-12-01)

Invasive pulmonary aspergillosis- early diagnosis in febrile neutropenic patients using high resolution CT scan of thorax as a screening tool
by: Shruti Prem, et al.
Published: (2014-08-01)

Клинический случай легочной формы мукормикоза у ребенка с острым лимфобластным лейкозом
by: D. A. Kharagezov, et al.
Published: (2021-12-01)

Chemotherapy-induced neutropenia and its determinants in patients with solid malignancies: A prospective observational study
by: Whitney Joseph J, et al.
Published: (2025-07-01)

Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy
by: Jim Abi Frem, et al.
Published: (2024-12-01)

Should to all patients with febrile neutropenia and colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae carbapenems be appointed?
by: V. A. Okhmat, et al.
Published: (2016-10-01)

Interleukin-6 versus C-reactive protein as markers for early detection of bacteremia in febrile neutropenia in pediatric population
by: Manasi Gupta, et al.
Published: (2020-01-01)

ITPA POLYMORPHISMS AND THE INCIDENCE OF TOXICITIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Patpetra Svasdisant, et al.
Published: (2023-02-01)

Adherence to guidelines for antibiotics used in the initial treatment of febrile neutropenia in patients with cancer: a study using health insurance claims database in Japan
by: Kanako Mizuno, et al.
Published: (2025-06-01)

Infección diseminada por Fusarium spp. en un paciente con anemia aplásica
by: Carolina Giraldo, et al.
Published: (2019-02-01)

Improving Prognostic Accuracy of MASCC Score with Lactate and CRP Measurements in Febrile Neutropenic Patients
by: Efe Kanter, et al.
Published: (2025-07-01)

A Retrospective Observational Cohort Analysis of Oncology Patients with Febrile Neutropenia in the Emergency Department of a Tertiary Care Hospital in Oman
by: Badar Al-Aamri, et al.
Published: (2025-01-01)

Neutrophil CD64 can be an early predictor for sepsis during febrile neutropenic episodes in children with cancer: a case control study
by: Marwa Zakaria, et al.
Published: (2025-05-01)

ECTHYMA GANGRENOSUM AND SEPTIC SHOCK CAUSED BY PSEUDOMONAS AERUGINOSA IN A CYTOTOXIC NEUTROPENIC PATIENT
by: I. A. Kurmukov, et al.
Published: (2017-10-01)

Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing <i>Klebsiella pneumoniae</i> for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study
by: Alessandra Micozzi, et al.
Published: (2024-10-01)

The microbiome role in pathogenesis of inflammatory and immune alterations of gastrointestinal tract in pediatric patients with cancer
by: D. A. Morgacheva, et al.
Published: (2021-06-01)

Novel treatment possibilities of invasive aspergillosis
by: G. A. Klyasova
Published: (2021-11-01)